A four year longitudinal sero-epidemiological study of bovine herpesvirus type-1 (BHV-1) in adult cattle in 107 unvaccinated herds in south west England
© Woodbine et al; licensee BioMed Central Ltd. 2009
Received: 26 February 2008
Accepted: 30 January 2009
Published: 30 January 2009
Bovine herpesvirus type-1 (BHV-1) is an important pathogen of cattle that presents with a variety of clinical signs, including the upper respiratory tract infection infectious bovine rhinotracheitis (IBR). A seroepidemiological study of BHV-1 antibodies was conducted in England from 2002 – 2004: 29,782 blood samples were taken from 15,736 cattle from 114 herds which were visited on up to three occasions. Antibody concentration was measured using a commercial ELISA. Farm management information was collected using an interview questionnaire, and herd size and cattle movements were obtained from the cattle tuberculosis testing database and the British Cattle Movement Service. Hierarchical statistical models were used to investigate associations between cattle and herd variables and the continuous outcome percentage positive (PP) values from the ELISA test in unvaccinated herds.
There were 7 vaccinated herds, all with at least one seropositive bovine. In unvaccinated herds 83.2% had at least one BHV-1 seropositive bovine, and the mean cattle and herd BHV-1 seroprevalence were 42.5% and 43.1% respectively. There were positive associations between PP value, age, herd size, presence of dairy cattle. Adult cattle in herds with grower cattle had lower PP values than those in herds without grower cattle. Purchased cattle had significantly lower PP values than homebred cattle, whereas cattle in herds that were totally restocked after the foot-and-mouth epidemic in 2001 had significantly higher PP values than those in continuously stocked herds. Samples taken in spring and summer had significantly lower PP values than those taken in winter, whereas those taken in autumn had significantly higher PP values than those taken in winter. The risks estimated from a logistic regression model with a binary outcome (seropositive yes/no) were similar.
The prevalence of BHV-1 seropositivity in cattle and herds has increased since the 1970s. Although the study population prevalence of BHV-1 was temporally stable during study period, the associations between serological status and cattle age, herd size, herd type, presence of young stock and restocked versus continuously stocked herds indicate that there is heterogeneity between herds and so potential for further spread of BHV-1 within and between herds.
Bovine herpesvirus type-1 (BHV-1) is a member of the family Herpesviridae, subfamily Alphaherpesvirinae. It is an important pathogen of cattle worldwide . Infection with BHV-1 causes a variety of clinical diseases including infectious bovine rhinotracheitis (IBR) (BHV-1 subtypes 1 and 2a), infectious pustular vulvovaginitis, infectious pustular balanoposthitis (BHV-1 subtype 2b) and encephalitis (BHV-1 subtype 3) . Conventional serological assays cannot distinguish between antigenic serotypes of BHV-1.
BHV-1 generally infects cattle greater than 6 months of age once maternal immunity has waned . Clinical signs associated with infection include nasal discharge, conjunctivitis, fever, inappetance, milk drop, abortion and, sometimes, death, although sub-clinical infection is possible [4, 5]. The virus is shed in secretions from the eyes, nose and reproductive organs. After initial infection and disease, cattle become carriers of the virus which becomes latent in the trigeminal or sacral ganglia. Reactivation of the virus may occur when cattle are stressed  and virus can then be transmitted to susceptible cattle. Infection can occur indirectly through contaminated material and wind borne particles .
BHV-1 has been in Great Britain (GB) since the 1960s . IBR was first confirmed in GB in 1961 [7, 8], but was not considered clinically important in GB until an outbreak of disease in Scotland in the late 1970s caused by a virulent strain of BHV-1 (subtype 1) [9–11]. In England and Wales, the overall prevalence of BHV-1 seropositive cattle was 2.1% in 1963 , rising to 15.1% of dairy and 16.8% of suckler cattle over 2 yrs of age in Norfolk in 1991 , and by 1992 BHV-1 antibodies were detected in 34% of cattle herds in the UK .
The reported risk factors for the presence of BHV-1 antibodies in cattle in the Netherlands included a large herd size, dairy herds with beef/veal cattle, a high density of herds in the municipality , purchasing cattle, cattle participating in shows, professional visitors not using farm protective clothing and herds situated close to other BHV-1 positive herds . In Belgium, seropositivity was associated with increasing cattle age and herd size and purchased cattle had a higher probability of being infected than homebred cattle [16, 17].
This paper presents the largest longitudinal study of BHV-1 seropositivity in cattle in the UK, and its association with cattle age, birthplace, herd type and size.
Source of data
The data used in this paper came from 114 dairy and/or suckler herds in south west England. Farms were visited between 2002 and 2006 and were located within the Randomised Badger Culling Trial (RBCT) . In addition, the study included some farms that had been depopulated in 2001 as a result of the foot-and-mouth disease (FMD) epidemic  and subsequently repopulated. All the farmers agreed to participate and allow their breeding cattle to be sampled.
Samples of blood (up to 10 ml) were collected under Home Office licence from all accessible cattle over 2 years of age at three routine visits, at approximately one year intervals. A subset of herds (n = 15) had a whole herd test, i.e. blood samples were collected from cattle of all ages, prompted by the presence of an animal persistently infected (PI) with bovine viral diarrhoea virus (BVDV). Four herds had a whole herd test instead of a routine third visit; otherwise whole herd tests were additional to routine tests.
All blood samples were centrifuged at the University of Warwick at 3220 g for 15 minutes, and serum was removed and frozen at -20°C.
Farmers completed an interview questionnaire between 17th June 2003 and 18th February 2004 to obtain information on clinical signs of infectious bovine rhinotracheitis (IBR) disease and use of a BHV-1 vaccine. Four out of 114 farmers did not complete the questionnaire.
At each visit, the unique identity of cattle was recorded from their ear tag and linked to the relevant blood sample. When appropriate, freeze brand numbers were also recorded. The ear tag was matched to the individual cattle data on the British Cattle Movement Service (BCMS) to obtain/confirm the following: the date of birth, whether the animal was homebred or purchased, breed and sex. More than 99% of cattle were matched within the BCMS dataset. The main reason that cattle were not matched was because they were born before 2001, when it was not compulsory to record cattle birth dates. Herd size was estimated from the cattle tuberculosis testing data (VetNet database), and validated during farm visits.
All data were entered into a relational database (PostgreSQL, PostgreSQL Global Development Group) using Microsoft Access (Microsoft Corp. US) as a front end. All data were screened for errors. When data mismatches were detected, data were re-checked to determine the source of the mismatch and where possible this was corrected.
Serological test and interpretation
The PP values ranged from -1.01 to 2.81. A sample was defined as positive when the OD > cut-off and negative when the OD < cut-off. The cut offs were:
Cut-off = 0.2when OD Negative control × 2.5 < 0.2
Cut-off = OD Negative control × 2.5when OD Negative control × 2.5 ≥ 0.2
It was not possible to differentiate antibodies stimulated through vaccination from those from natural infection and so the 7 vaccinated herds were excluded from the analysis.
The full serological dataset consisted of 29,782 ELISA results. Date of birth and identification of cattle were not available for 1,838 and 344 observations respectively. For the purpose of this study, two datasets (A and B) were used. Dataset A included all serological results for all cattle from herds that were not vaccinated against BHV-1 for all visits (26,918 samples, 14,243 cattle, 107 herds). Dataset B was a subset of Dataset A and included all serological results from cattle >2 years of age from the three routine visits and 4 whole herd visits (24,182 samples, 12,764 cattle, 107 herds).
A herd was defined as BHV-1 seropositive when at least one cow in the herd was above the cut off for BHV-1 on at least one occasion.
Cattle were defined as BHV-1 seropositive when above the cut off for BHV-1 at least once.
The herd BHV-1 seroprevalence was calculated at each visit as the number of seropositive cattle in the herd divided by the total number of cattle tested.
Seroconversion was defined in a herd when at least one cow changed from being seronegative to seropositive between two visits.
Two outcomes were modelled to investigate associations between BHV-1 seropositivity and herd and cow variables. These were the continuous outcome PP, and a binary (positive/negative) outcome (seropositive yes/no).
The explanatory variables
The explanatory variables in the repeated measures multi-level model (Tables 3 and 4).
Treatment in the Random Badger Culling Trial (RBCT)
Herd was depopulated due to the foot-and-mouth (FMD) epidemic in 2001
Geographical area (farm location)
Geographical area, which the farm was situated in, categorised as Area A-(Gloucestershire, Herefordshire/Worcestershire), Area B-(northeast Devon, south Somerset), Area C-(northwest Devon, northeast Cornwall)
Cattle age (years)
In yearly intervals from 2 years old up to 10 years and over
Taken from the VetNet database the average number of cattle present in the herd during the study period
Birthplace of replacement cattle
Cattle were homebred (tested in natal herd) or purchased (tested in herd different from natal herd)
Yes or no dairy cattle were present in the herd
Yes or no grower cattle were present in the herd
Time when visit took place. Winter (December, January and February), Spring (March, April and May), Summer (June, July and August) and Autumn (September, October and November)
Associations between the outcomes and herd and animal factors were initially screened using Mann-Whitney and chi-squared tests. Variables with a significance value of <0.20 in the univariate analysis were tested in two multi-level models: one with a continuous outcome of PP value and one with a binary outcome of seropositive yes/no. There were three hierarchical levels in the models: repeated measure at each visit (level 1), clustered by cow (level 2), and herd (level 3) to control for the dependency between repeated measures within cattle and cattle within herds. The multivariable models were built using both manual forward selection and backwards elimination.
where Y ijk is the PP value or seropositivity value at visit i from cow j in herd k. βX 0 is the intercept, βX is a series of vectors of fixed effect varying at the herd (k), cattle (jk) and visit (ijk), ν k + u jk are the variances at the herd and cattle levels, and e ijk is the residual variance.
The model fit was assessed by plotting the raw, standardised and deletion residuals, and the leverage and influence for each random effect and all fixed effects were also assessed . The detection of outliers in the models was completed using a top-down approach : outliers at level 3 (herds) were examined first, and then the lower level clusters (cattle and visits). A model which included only the seropositive herds in Dataset B was also built using the procedure above.
Correlations between the explanatory variables were investigated using chi-squared tests. Variables that were significantly (P < 0.01) associated with each other were noted to help with interpretation. All analyses were done using MLwiN version 2.02 (Centre for Multilevel Modelling, Bristol, UK) .
All 107 unvaccinated herds were visited at least once, 96 were visited twice and 95 were visited on three occasions, generating 9136, 8099 and 7850 serum samples, respectively. A further 1833 blood samples were collected from additional visits or because of a whole herd test and/or cattle were under 2 years of age.
Vaccination and clinical signs
The median herd size of vaccinated herds was 274; in contrast, the median herd size of unvaccinated herds was 185. The median herd size of unvaccinated seronegative and seropositive herds was 58 and 193, respectively. Nine percent (10/114) of farmers reported that they had seen clinical signs of IBR in their herd in the past, and two of these farmers also reported that they now vaccinated their cattle. All vaccinated herds had at least one seropositive animal compared with 83.2% of unvaccinated herds with at least one seropositive animal. The mean within-herd seroprevalence in vaccinated herds was 74.9% compared with 43.2% in unvaccinated herds.
Herd and cattle BHV-1 seroprevalence
Number and percentage of seropositive BHV-1 herds and cattle by visit type for Dataset A (26,918 samples, 14,243 cattle, 107 herds), and herd BHV-1 antibody seroprevalence for positive herds only.
Herd seroprevalence for positive herds
1st routine visit
0.9 – 95.9
(2.1 – 95.9)
2nd routine visit
2.7 – 95.9
(2.9 – 95.9)
3rd routine visit/3rd routine and whole herd visit
2.4 – 99.2
(2.4 – 99.2)
Other non-routine visits
43.8 – 100.0
(43.8 – 100.0)
73.1 – 75.0
(73.1 – 75.0)
Given the reported sensitivity and specificity of the ELISA, approximately 700 and 2,046 cattle tests during the study are expected to be false negatives and false positives, respectively. There were 124 cattle that tested positive and then negative at subsequent visits. In addition, 85 cattle changed serological status twice: 25 cattle tested positive, negative then positive and 60 cattle tested negative, positive then negative. Note that we assume that antibody positivity remains for life after infection; if antibody titre wanes with time since infection, then a conversion from positive to negative might reflect a true status rather than a test failure.
Univariate associations with BHV-1 antibody seroprevalence
Descriptive statistics of the type of herd and number of BHV-1 seropositive unvaccinated herds (Dataset A, see methods section).
Cattle prevalence in positive herds
Mean number of cattle present in herd
No. positive herds
Total No. herds
Suckler with grower herd
Suckler with grower herd
Dairy with grower herd
Dairy with grower herd
Hierarchical model results
Repeated measures multi-level model of 10,039 cattle from 102 unvaccinated herds with PP BHV-1 levels as the continuous outcome and seropositive yes/no as the discrete outcome (Dataset B, see methods section).
Triplet code a
The sum of the level 1, level 2, and level 3 variances was 0.28. The greatest unexplained variance in PP values in the final multi-level model was between cattle, making up 48% of the total variance. However, the variances were significant at all three levels (Table 4).
The estimated risks were similar when a multi-level binary logistic regression model (outcome seropositive yes/no) was fitted (Table 4). The variables that did not remain significant were whether cattle were homebred or purchased and whether herds had grower cattle.
This is the largest seroepidemiological study of BHV-1 carried out in cattle herds in the UK, and the first for more than 15 years. The seroprevalence of BHV-1 has increased dramatically since the 1960s in both cattle and herds. In the 1960s the seroprevalence in cattle was 2.1% , whilst in the current study, 42.5% of cattle always tested positive. Similarly, the herd prevalence was 20% in 1974 , and 83.2% in the current study. The differences in herd seroprevalence between the current and previous studies could be explained in part if the herds in this study were biased towards a particular location, age or cattle purpose since these were factors that influenced herd seroprevalence (Table 4). However, the consistency of seropositivity across the farms in this study over the 3 year time period suggests that infection has reached a temporal equilibrium, or possibly that seropositivity is increasing slowly.
A particularly interesting result is the higher seroprevalence in herds that were restocked after FMD. Carrique-Mas et al. (2008)  reported that bovine tuberculosis could be introduced into a farm at restocking when cattle were bought from herds with high incidence of infection. It is highly likely that purchase will have brought BHV-1 into restocked herds. The reason for the apparent increase in seroprevalence of BHV-1 is unknown but it might be that movement and mixing in new herds is stressful for cattle, resulting in recrudescence of virus in infected cattle that then infect susceptible cattle in the newly formed herd. In non-restocked herds, purchased cattle had a lower seroprevalence, which is contradictory to this explanation. It should also be remembered that the vaccination status of individual cattle is unknown so that the difference in seroprevalence might be explained by differences in purchasing vaccinated cattle, especially in dairy herds. There may also be complex interactions between cattle age, purchasing and restocking, since restocking of herds is very different to "routine" purchase. Additionally, the existence of multiple antigenic types (which cannot be distinguished serologically) means that interpretation of seroepidemiology is not straightforward. Whatever the cause, these results suggest that these purchased cattle were associated with a high herd seroprevalence and highlight the point that farmers should consider the antibody BHV-1 status of cattle before introduction, to prevent concomitant introduction or re-introduction of BHV-1 of the same or a different antigenic type, that might influence disease presentation.
The seroprevalence of BHV-1 increased with herd size in the univariate analysis and in the hierarchical model; this is consistent with other studies [16, 26–28]. The association with herd size was greater in herds where seroconversion occurred during the study (Figure 2), suggesting that active transmission is related positively to herd size, perhaps because larger herds have more potential transmission contacts both within the herd and with other herds (e.g. from veterinarians, other farmers and purchased cattle). However, the association between BHV-1 PP values and herd size might be confounded with other factors associated with herd size, e.g. recrudescence of infection through stress , or exposure to more viral types.
The age serological profile is consistent with life-long seropositivity. Antibodies to BHV-1 in calves of ≤ 6 months of age probably correspond to colostrum derived maternal immunity. This wanes by 1 year of age, and starts to rise by 2 years of age because of active infection. This suggests that the optimum age for vaccination of cattle is 10 – 14 months of age, although with some active seroconversion observed in adult cattle and a seroprevalence only exceeding 50% in older animals, vaccination is likely to have a positive impact when administered at any age. All the vaccinated herds had seropositive cattle, while approximately 80% of the unvaccinated herds had seropositive cattle. On average, less than 50% of the cattle in the unvaccinated herds tested positive at each visit, whilst >75% of the cattle from vaccinated herds were positive. These data suggest that either some cattle in vaccinated herds were not vaccinated, that vaccination does not always induce antibody or that antibody titre induced by vaccination wanes over time. It is possible that antibody titre generated by natural infection also wanes over time, but there is no previous work on this hypothesis.
In the current study, when the herd was a dairy herd rather than a suckler herd, the rate of seroconversion in adults was greater. The average age of cattle did not differ between dairy and suckler herds, and so this is a true effect, possibly due to winter housing or other stressors related to dairy cow management.
Housing and winter stressors are also an explanation for the small but significant effect of season on PP values. However, 31% and 47% of visits were 11–13 months apart for routine visits 1 and 2 and routine visits 2 and 3, respectively, so that there was a tendency for the same herds to be sampled in the same season and so herd effect is interpreted as an apparent seasonal effect. Other explanations are that seasonal culling and replacement of cattle might influence herd prevalence of BHV-1 antibodies.
All the variables above became non-significant when the binary variable seroconversion (indicating whether seroconversion was observed in the herd) was introduced into the final model. This indicates that the model risk factors are those associated with virus circulation between cattle on the farm.
The use of different modelling approaches has been discussed elsewhere [28, 30] but not modelling different distributions of the same outcome. We compared these two outcomes because we wanted to investigate change in antibody level that was not necessarily occurring around the cut off. The associated risks were similar to those in Table 4 whether the data were modelled using a continuous or binary outcome, but the presence of grower cattle and purchased or homebred were not statistically significant in the binomial model, although the trends were in the same direction of risk. This suggests that these variables alter the antibody titre either always above or below the cut off and that this change was detectable in the continuous outcome model but not in the discrete model.
In the discrete model, we assumed that the serological measurement of seropositive/seronegative had perfect sensitivity and specificity. It is possible that bias could be introduced into the analysis if the sensitivity or specificity of the test varied with other variables, for example, with cattle age, or time since infection, however this has not been reported for BHV-1 antibody tests. The continuous outcome (PP) calculated from the ELISA will have had some random error (Figure 4), but avoided the need to categorise cattle as positive or negative to BHV-1 antibody, and avoided the possibility of misclassification due imperfect sensitivity and specificity, although would have retained a bias if serological measurement varied with other variables. However, the consistency between the discrete and continuous outcome models suggests that sensitivity and specificity do not alter with any of the explanatory variables in the model.
The results of this study do not necessarily represent all cattle herds in England, because of the locality of the farms sampled and because the analysis was based primarily on the serological values for BHV-1 from adult cattle. Using only unvaccinated herds in the study may have reduced the extrapolation of the results, because these herds may have had different management practices from vaccinated herds, but there were only 7 herds that reportedly used vaccination and so analysis of these herds' managements was not possible. In addition, there might have been an overestimation of the infection derived seroprevalence because purchased cattle might have been sourced from a vaccinated herd and so had antibodies derived from vaccination: we do not know the vaccination status of source herds. The serological test used in the current study did not distinguish between vaccine derived and pathogen derived antibody so this was unavoidable. It is interesting that only 7 herds were vaccinated and that farmers reported little clinical disease from BHV-1, suggesting that this infection is not an obvious production constraint or clinical disorder in most herds.
Finally, in the current analysis we could not distinguish between BHV-1 sub-types, the epidemiology of individual types might be different and this might account for some of the unexplained heterogeneity. BHV-1 subtype 3 is now classified as a new species (bovine herpesvirus-5 or BHV-5) . It is probable that we were detecting antibodies to BHV-5 as well as BHV-1 because these viruses are antigenically related.
In conclusion, the level of BHV-1 infection has increased dramatically since previous estimates from the UK, with approximately 83% of the unvaccinated herds in the south west of England seropositive. This study adds to previous work with the finding that infection might have reached a temporal but not a spatial equilibrium and that between herd variability in PP might arise through variability in cattle age, herd size, herd purpose and the formation of new herds.
We acknowledge financial support from DEFRA (SE3026) for the access to the cattle in the cohort study and BBSRC (grant number BBS/B/04854) for funding the analysis of the sera and analytical research. We are grateful for the active contribution of all the farmers, and we thank all the technicians who helped with data collection and ELISA testing.
- Wyler R, Engels M, Schwyzer M: Infectious bovine rhinotracheitis/vulvovaginitis (BHV-1). Herpesvirus Diseases of Cattle, Horses and Pigs. Edited by: Wittmann G. Kluwer Academic Publishers, Boston, Dordrecht, London; 1989:1-72.View Article
- Wentink GH, van Oirschot JT, Verhoef J: Risk of infection with bovine herpesvirus 1 (BHV 1): a review. Vet Q. 1993, 15: 30-33.View ArticlePubMed
- Bennett R, Ijpelaar J: Economic Assessment of Livestock Diseases in Great Britain. The University of Reading; 2003.
- Ackermann M, Müller HK, Bruckner L, Kihm L: Eradication of infectious bovine rhinotracheitis in Switzerland: review and prospects. Vet Microbiol. 1990, 23: 365-370. 10.1016/0378-1135(90)90168-U.View ArticlePubMed
- van Oirschot JT, Straver PJ, van Lieshout JAH, Quak J, Westenbrink F, van Exsel ACA: A subclinical infection of bulls with bovine herpesvirus type 1 at an artificial insemination centre. Vet Rec. 1993, 132: 32-5.View ArticlePubMed
- Dawson PS, Darbyshire JH: The occurrence and distribution in the United Kingdom of antibodies to parainfluenza 3 and infectious bovine rhinotracheitis viruses in bovine sera. Vet Rec. 1964, 76: 111-115.
- Darbyshire JH, Dawson PS, Paterson AB: The isolation of infectious bovine rhinotracheitis virus in the United Kingdom: A preliminary report. Vet Rec. 1962, 74: 156-157.
- Dawson PS, Darbyshire JH, Loosemore RM, Paterson AB, Faull WB: Infectious bovine rhinotracheitis (IBR). A clinical condition of cattle occurring in the United Kingdom. Vet Rec. 1962, 74: 1379-1383.
- Wiseman A, Msolla PM, Selman IE, Allan EM, Cornwell HJC, Pirie HM, Imray WS: An acute severe outbreak of infectious bovine rhinotracheitis: Clinical, epidemiological, microbiological and pathological aspects. Vet Rec. 1978, 103: 391-397.View ArticlePubMed
- Edwards S, White H, Nixon P: A study of the predominant genotypes of bovid herpesvirus 1 found in the U.K. Vet Microbiol. 1990, 22: 213-223. 10.1016/0378-1135(90)90108-8.View ArticlePubMed
- Edwards S, Newman RH, White H: The virulence of British isolates of bovid herpesvirus 1 in relationship to viral genotype. Br Vet J. 1991, 147: 216-231.View ArticlePubMed
- Pritchard GC: Epidemiology of BHV1 infection in cattle breeding herds in Norfolk. Proceedings of the Society for Veterinary Epidemiology and Preventive Medicine, Edinburgh, 1–3 April, 1992. 1992, 168-185.
- Hogg AA: UK bovine respiratory virus serosurvey (1991/92). Proceedings of the British Cattle Veterinary Association, 1992. 1992, 347-352.
- van Wuijckhuise L, Bosch J, Franken P, Krankena K, Elbers AR: Epidemiological characteristics of bovine herpesvirus 1 infections determined by bulk milk testing of all Dutch dairy herds. Vet Rec. 1998, 142: 181-184.View ArticlePubMed
- van Schaik G, Dijkhuizen AA, Huirne RB, Schukken YH, Nielen M, Hage HJ: Risk factors for existence of bovine herpes virus 1 antibodies on nonvaccinating Dutch dairy farms. Prev Vet Med. 1998, 34: 125-136. 10.1016/S0167-5877(97)00085-8.View ArticlePubMed
- Boelaert F, Speybroeck N, de Kruif A, Aerts M, Burzykowski T, Molenberghs G, Berkvens DL: Risk factors for bovine herpesvirus-1 seropositivity. Prev Vet Med. 2005, 69: 285-295. 10.1016/j.prevetmed.2005.02.010.View ArticlePubMed
- Faes C, Hens N, Aerts M, Shkedy Z, Geys H, Mintiens K, Laevens H, Boelaert F: Estimating herd-specific force of infection by using random-effects models for clustered binary data and monotone fractional polynomials. Appl Statist. 2006, 55: 595-613.
- Bourne J: Bovine TB: The Scientific Evidence. A science base for a sustainable policy to control TB in cattle. An epidemiological investigation into bovine tuberculosis. Defra Final Report. 2007.
- Keeling MJ, Woolhouse ME, May RM, Davies G, Grenfell BT: Modelling vaccination strategies against foot-and-mouth disease. Nature. 2003, 421: 136-142. 10.1038/nature01343.View ArticlePubMed
- Torstensson M: Personal communication. (Svanova). 2007.
- Fowler J, Cohen L, Jarvis P: Practical Statistics for Field Biology.Second edition. John Wiley & Sons; 1998:166.
- Langford IH, Lewis T: Outliers in multilevel data. J R Statist Soc A. 1998, 161: 121-160. 10.1111/1467-985X.00094.View Article
- Rasbash J, Browne W, Goldstein H, Yang M, Plewis I, Healy M, Woodhouse G, Draper D, Langford I, Lewis T: A user's guide to MLwiN version 2.1d for use with MLwiN 1.10. Centre for Multilevel Modelling. Institute of Education, University of London; 2000.
- Kirby FD, Martin HT, Waring MJ: A serological survey on the prevalence of infectious bovine rhinotracheitis in Buckinghamshire, Berkshire and Oxfordshire. Vet Rec. 1978, 103: 134-136.View ArticlePubMed
- Carrique-Mas JJ, Medley GF, Green LE: Risks for bovine tuberculosis in British cattle farms restocked after the foot and mouth disease epidemic of 2001. Prev Vet Med. 2008, 84: 85-93. 10.1016/j.prevetmed.2007.11.001.View ArticlePubMed
- McDermott JJ, Kadohira M, O'Callaghan CJ, Shoukri MM: A comparison of different models for assessing variations in the sero-prevalence of infectious bovine rhinotracheitis by farm, area and district in Kenya. Prev Vet Med. 1997, 32: 219-34. 10.1016/S0167-5877(97)00025-1.View ArticlePubMed
- Solis-Calderon JJ, Segura-Correa VM, Segura-Correa JC, Alvarado-Islas A: Seroprevalence of and risk factors for infectious bovine rhinotracheitis in beef cattle herds of Yucatan, Mexico. Prev Vet Med. 2003, 57: 199-208. 10.1016/S0167-5877(02)00230-1.View ArticlePubMed
- Speybroeck N, Boelaert F, Renard D, Burzykowski T, Mintiens K, Molenberghs G, Berkvens D: Design-based analysis of surveys: a bovine herpesvirus 1 case study. Epidemiol Infect. 2003, 13: 991-1002. 10.1017/S095026880300102X.View Article
- Enevoldsen C, Hindhede J, Kristensen T: Dairy herd management types assessed from indicators of health, reproduction, replacement, and milk production. J Dairy Sci. 1996, 79: 1221-36.View ArticlePubMed
- Schukken YH, Grohn YT, McDermott B, McDermott JJ: Analysis of correlated discrete observations: background, examples and solutions. Prev Vet Med. 2003, 59: 223-240. 10.1016/S0167-5877(03)00101-6.View ArticlePubMed
- Roizman B, Desrosiers RC, Fleckenstein , Lopez C, Minson AC, Studdert MJ: The family Herpesviridae : an update. Arch Virol. 1992, 123: 425-449. 10.1007/BF01317276.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.